SCHEMBL6002907

SCHEMBL6002907

CCO[CH]C(=O)Nc1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.55
ALDH1A1 P00352 1/20 0.55
USP2 O75604 1/20 0.52
HPGD P15428 1/20 0.52
TP53 P04637 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
NPC1 O15118 2/20 0.51
EGFR P00533 1/20 0.51
LMNA P02545 2/20 0.49
GAA P10253 1/20 0.49
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2095754 0.83 MAPT (0.59) MAPTALDH1A1USP2HPGDTP53
SCHEMBL6333143 0.77 MAPT (0.63) MAPTALDH1A1USP2HPGDSMN1; SMN2
SCHEMBL28534849 0.75 TP53 (0.65) MAPTALDH1A1USP2HPGDTP53
SCHEMBL6002909 0.75 HPGD (0.69) MAPTALDH1A1USP2HPGDSMN1; SMN2
SCHEMBL31162463 0.74 EGFR (0.59) MAPTALDH1A1USP2HPGDTP53
SCHEMBL11336614 0.74 EGFR (0.59) MAPTALDH1A1USP2HPGDTP53
SCHEMBL11578349 0.74 HPGD (0.65) MAPTALDH1A1USP2HPGDSMN1; SMN2
SCHEMBL10631063 0.73 HPGD (0.72) MAPTALDH1A1USP2HPGDSMN1; SMN2
SCHEMBL11861472 0.73 ALDH1A1 (0.58) MAPTALDH1A1USP2HPGDTP53
SCHEMBL11861465 0.73 ALDH1A1 (0.58) MAPTALDH1A1USP2HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed